Thousands monitored in Real-World vaccine safety study
NCT ID NCT07444502
First seen Mar 10, 2026 · Last updated May 05, 2026 · Updated 7 times
Summary
This study checked the safety of the TdaP vaccine Boostagen® after it was already approved in Thailand. Over 10,000 people who got the vaccine in regular doctor visits were watched for side effects. The goal was to see how safe the vaccine is in a large, real-world group, including pregnant women and their babies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TETANUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
BioNet-Asia Co., Ltd.
Bangkok, 10260, Thailand
Conditions
Explore the condition pages connected to this study.